That is misleading. It is not an 18% reduction. It is an 18% reduction vs the placebo. They are currently already on the current standard of care, and this is outperforming that. If a drug outperforms standard of care, that is a very positive result!
That is misleading. It is not an 18% reduction. It is an 18%...
-
- There are more pages in this discussion • 595 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.5¢ |
Change
0.015(2.94%) |
Mkt cap ! $288.8M | |||
| Open | High | Low | Value | Volume |
| 51.5¢ | 54.5¢ | 51.0¢ | $1.206M | 2.318M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 41428 | 52.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.5¢ | 15832 | 2 |
View Market Depth
| Last trade - 13.37pm 28/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |